SS Innovations International (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system will be featured at the 2026 Society of Robotic Surgery Annual Meeting, taking place July 23-26 in Hollywood, Florida. The system will be displayed throughout the event, highlighted in multiple breakout sessions, and used in a live broadcast of a remote partial nephrectomy performed by Dr. Amitabh Singh from the company’s headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi.
Chairman and CEO Dr. Sudhir Srivastava will participate as a speaker and panelist in multiple sessions covering telesurgery, robotic surgery adoption, regulatory frameworks, and global access to robotic care. As of July 6, 2026, the SSi Mantra system had been used in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries, while approximately 2,100 physicians have been trained on the platform.
The significance of this announcement lies in the demonstration of remote surgical capabilities, which could expand access to specialized care in underserved regions. The live broadcast of a telesurgery from India to Florida underscores the potential for surgical robots to overcome geographical barriers. For the industry, this event highlights the growing adoption of robotic surgery and the importance of regulatory frameworks to support telesurgery. For patients, it suggests a future where expert surgeons can operate on patients anywhere in the world, potentially reducing wait times and improving outcomes.
SS Innovations develops surgical robotic technologies with a vision to make robotic surgery affordable and accessible globally. The company’s product range includes the SSi Mantra system and the SSi Mudra surgical instruments, which support various procedures including cardiac surgery. As an American company headquartered in India, SS Innovations plans to expand the global presence of its cost-effective surgical robotic solutions. More details can be found in the full press release at https://ibn.fm/YYYKE.
Forward-looking statements in this article involve risks and uncertainties as detailed in the company’s SEC filings. For more information, refer to the terms of use and disclaimers on the InvestorBrandNetwork website at http://IBN.fm/Disclaimer.
